Journal of Cancer Research and Therapeutics Close
 

Figure 5: The flow cytometry study showing 11.08 % of the cells in the gated region R1 (a) positive for CD117 (b); 0.83% for CD34 (c); 87% for CD13 (d); 92.23% for CD33 (e); and 93.67% for CD45 (f)

Figure 5: The flow cytometry study showing 11.08 % of the cells in the gated region R1 (a) positive for CD117 (b); 0.83% for CD34 (c); 87% for CD13 (d); 92.23% for CD33 (e); and 93.67% for CD45 (f)